Legal & General Group PLC Repare Therapeutics Inc. Transaction History

Legal & General Group PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$3.22 - $11.79 $38,736 - $141,833	-12,030 Reduced 94.46%	706 $5,000
Q2 2023 Aug 14, 2023	BUY	$8.63 - $12.53 $64,949 - $94,300	7,526 Added 144.45%	12,736 $134,000
Q1 2023 May 15, 2023	BUY	$9.32 - $15.06 $5,377 - $8,689	577 Added 12.45%	5,210 $51,000
Q2 2022 Aug 22, 2022	BUY	$8.45 - $14.84 $5,999 - $10,536	710 Added 18.1%	4,633 $65,000
Q4 2021 Feb 14, 2022	BUY	$19.66 - $28.11 $27,524 - $39,354	1,400 Added 55.49%	3,923 $83,000
Q3 2021 Nov 15, 2021	BUY	$25.71 - $35.24 $46,715 - $64,031	1,817 Added 257.37%	2,523 $67,000
Q1 2021 May 17, 2021	BUY	$25.89 - $44.46 $18,278 - $31,388	706 New	706 $22,000
Q3 2020 Nov 13, 2020	SELL	$21.55 - $33.92 $10,775 - $16,960	-500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.8 - $32.99 $15,400 - $16,495	500 New	500 $16,000

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $55.4M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.